Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003818
Filing Date
2020-03-12
Accepted
2020-03-12 16:26:34
Documents
107
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2177951
2 ex4-2.htm EX-4.2 21307
3 ex10-6.htm EX-10.6 22974
4 ex10-25.htm EX-10.25 169367
5 ex21-1.htm EX-21.1 5822
6 ex23-1.htm EX-23.1 4110
7 ex31-1.htm EX-31.1 18140
8 ex31-2.htm EX-31.2 18137
9 ex32-1.htm EX-32.1 8600
10 form10-k_001.jpg GRAPHIC 19475
11 form10-k_002.jpg GRAPHIC 33558
12 form10-k_003.jpg GRAPHIC 15862
13 form10-k_004.jpg GRAPHIC 31309
  Complete submission text file 0001493152-20-003818.txt   9262725

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE lctx-20191231.xml EX-101.INS 1266778
15 XBRL SCHEMA FILE lctx-20191231.xsd EX-101.SCH 108056
16 XBRL CALCULATION FILE lctx-20191231_cal.xml EX-101.CAL 108103
17 XBRL DEFINITION FILE lctx-20191231_def.xml EX-101.DEF 548599
18 XBRL LABEL FILE lctx-20191231_lab.xml EX-101.LAB 713227
19 XBRL PRESENTATION FILE lctx-20191231_pre.xml EX-101.PRE 599347
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12830 | Film No.: 20709154
SIC: 2836 Biological Products, (No Diagnostic Substances)